Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Mar 7;8(1):4162.
doi: 10.1038/s41598-018-22481-9.

Results of the national organised colorectal cancer screening program with FIT in Paris

Anna Pellat  1   2 , Jacques Deyra  3 , Romain Coriat  4   3 , Stanislas Chaussade  4   3
Affiliations
Clinical Trial

Results of the national organised colorectal cancer screening program with FIT in Paris

Anna Pellat et al. Sci Rep. .

Abstract

In France, colorectal cancer (CRC) benefits from a nationwide screening program. The faecal immunochemical test (FIT) is being used since April 2015. The test is recommended in asymptomatic patients followed by a colonoscopy if positive for identification and treatment of colorectal lesions. We investigate the CRC national organised screening program using FIT in Paris. We performed a retrospective observational study, collecting data from the screening program in Paris using the ADECA75 database. Rates of participation, numbers of positive FIT, detection rates and positive predictive values (PPV) for advanced adenomas (AA) and/or CRC were determined. Between 01/01/2016 and 30/06/2017, 620.227 Parisians were eligible and 409.340 were invited to participate to the program. A total of 88.796 participants (23%) performed the test with 3.839 positive tests (4.3%). In the positive test population, 2.706 out of 3.839 individuals (70.5%) performed the required colonoscopy with available reports. Histology reports were only available for 2.401 participants (88,7%). Regarding lesions, 733 (30,5%) and 205 patients (8.5%) had AA and CRC, respectively. Over 18 months of screening with FIT in Paris, the PPV is in line with expected results while the participation rate is below European recommendations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow chart of the Parisian population participating in the organised CRC screening program between 01/01/2016 and 30/06/2017.
See this image and copyright information in PMC

References

    1. Shaukat A, et al. Long-term mortality after screening for colorectal cancer. N. Engl. J. Med. 2013;369:1106–1114. doi: 10.1056/NEJMoa1300720. - DOI - PubMed
    1. Hol L, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59:62–68. doi: 10.1136/gut.2009.177089. - DOI - PubMed
    1. van Rossum LG, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90. doi: 10.1053/j.gastro.2008.03.040. - DOI - PubMed
    1. Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev. Med. 2012;55:87–92. doi: 10.1016/j.ypmed.2012.05.006. - DOI - PubMed
    1. Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: An update. World J. Gastroenterol. 2017;23:3632–3642. doi: 10.3748/wjg.v23.i20.3632. - DOI - PMC - PubMed